510(k) device
BD BACTEC Myco/F Lytic Culture Vials
Becton, Dickinson and Company · System, Blood Culturing (MDB, Class I) · First FDA decision Mar 24, 2023, newest Mar 24, 2023Sepsis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "BD BACTEC Myco"
MAUDE reports
14
Brand "BD BACTEC Myco", since 2015
PubMed studies
0
Mentioning "BD BACTEC Myco"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing BD BACTEC Myco/F Lytic Culture Vials
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K222559 · Decided Mar 24, 2023 · 212 days after receipt
Device type: System, Blood Culturing (MDB) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "BD BACTEC Myco", any status and sponsor, newest update first.
No registered device study names "BD BACTEC Myco".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "BD BACTEC Myco", and for the whole product code for context.
This brand
14 reports: 13 malfunction, 1 injury, 0 death
Whole product code MDB
6,473 reports: 6,328 malfunction, 134 injury, 10 death
Newest reports for this brand
- BD BACTEC¿ MYCO/F LYTIC CULTURE VIALSMalfunction
2647876-2025-00658 · Received Nov 4, 2025 · Event dated Oct 15, 2025
Device type: System, Blood Culturing (MDB)
Device problem as coded: False Negative Result
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "BD BACTEC Myco"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MDB.
- BD BACTEC Plus Aerobic/F Culture VialsBecton, Dickinson and Company · 510(k) 2023
- BacT/ALERT FA PlusbioMerieux, Inc. · 510(k) 2019
- BACT/ALERT MP Reagent SystembioMerieux, Inc. · 510(k) 2019
- BD BACTEC Peds Plus/F Culture Vials Soybean-Casein Digest Broth with Resins in a Plastic VialBecton, Dickinson and Company · 510(k) 2018
- BD BACTEC Standard/10 Aerobic/F Culture Vials Soybean-Casein Digest Broth in a Plastic VialBecton Dickinson · 510(k) 2017
- Bact/Alert Fn Plus Culture BottlebioMerieux, Inc. · 510(k) 2013
- Bact/Alert Pf Plus Culture BottlebioMerieux, Inc. · 510(k) 2013
- BD BACTEC FXI Culture SystemBD Diagnostic Systems · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.